Author

Jason L. DeHart

Observed names: DeHart, Jason L, J L DeHart, Jason DeHart, Jason Dehart, Jason L DeHart, Jason L. Dehart

Observed institutions: Sanford Burnham Prebys Medical Discovery Institute, SUNY Upstate Medical University, University of Utah, Synthetic Genomics (United States)

ORCID: 0000-0001-6894-1534

Observed ORCID: 0000-0001-6894-1534

OpenAlex ID: A5039400896

HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system

2007 · Jason L DeHart, Erik S Zimmerman, et al. · Virology Journal · 152

HIV-1 Vpr Triggers Natural Killer Cell–Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response

2009 · Jeffrey Ward, Zachary Davis, et al. · PLoS Pathogens · 141

Human Immunodeficiency Virus Type 1 Vpr-Mediated G2 Arrest Requires Rad17 and Hus1 and Induces Nuclear BRCA1 and γ-H2AX Focus Formation

2004 · Erik S. Zimmerman, Junjie Chen, et al. · Molecular and Cellular Biology · 119

HIV-1 Vpr-Induced Apoptosis Is Cell Cycle Dependent and Requires Bax but Not ANT

2006 · Joshua L. Andersen, Jason L. DeHart, et al. · PLoS Pathogens · 115

A Role for ATF2 in Regulating MITF and Melanoma Development

2010 · Meera Shah, Anindita Bhoumik, et al. · PLoS Genetics · 81

Human Immunodeficiency Virus Type 1 Vif Induces Cell Cycle Delay via Recruitment of the Same E3 Ubiquitin Ligase Complex That Targets APOBEC3 Proteins for Degradation

2008 · Jason L. DeHart, Alberto Bosque, et al. · Journal of Virology · 58

ATR and GADD45α mediate HIV-1 Vpr-induced apoptosis

2005 · J L Andersen, E S Zimmerman, et al. · Cell Death and Differentiation · 58

Human Immunodeficiency Virus Type 1 Vpr Links Proteasomal Degradation and Checkpoint Activation

2007 · Jason L. DeHart, Vicente Planelles · Journal of Virology · 49

The Ataxia Telangiectasia-Mutated and Rad3-Related Protein Is Dispensable for Retroviral Integration

2005 · Jason L. DeHart, Joshua L. Andersen, et al. · Journal of Virology · 43

CD8 + T cells mediate protection against Zika virus induced by an NS3-based vaccine

2020 · Annie Elong Ngono, Thasneem Syed, et al. · Science Advances · 36

Self-Replicating RNAs Drive Protective Anti-tumor T Cell Responses to Neoantigen Vaccine Targets in a Combinatorial Approach

2020 · Christian J. Maine, Guilhem Richard, et al. · Molecular Therapy · 28

Induction of G 2 Arrest and Binding to Cyclophilin A Are Independent Phenotypes of Human Immunodeficiency Virus Type 1 Vpr

2006 · Orly Ardon, Erik S. Zimmerman, et al. · Journal of Virology · 24

393 DISP-10 is a novel CAR T and tumor-specific virus combination undergoing clinical development that is designed for use as a universal treatment for epithelial tumors

2025 · Lisa Cucolo, Surabhi Srinivasan, et al. · Regular and Young Investigator Award Abstracts · 1

CD8+ T cells mediate an NS3-based vaccine protection against Zika virus

2020 · Annie Elong Ngono, Thasneem Syed, et al. · The Journal of Immunology

From Foe to Friend: Therapeutic and Commercial Applications of Engineered Viruses

2018 · Jason L DeHart, Kurt I Kamrud · Encyclopedia of Life Sciences

Works count: 20

Citation count: 905

H-index: 12

I10-index: 12